CMV-associated T cell and NK cell terminal differentiation does not impact immunogenicity of ChAdOx1 vaccination

Sharpe HR., Provine NM., Bowyer GS., Moreira Folegatti P., Belij-Rammerstorfer S., Flaxman A., Makinson R., Hill AVS., Ewer KJ., Pollard AJ., Klenerman P., Gilbert S., Lambe T.

DOI

10.1172/jci.insight.154187

Type

Journal article

Journal

JCI Insight

Publisher

American Society for Clinical Investigation

Publication Date

22/02/2022

Permalink Original publication